RxDoctor Payments Data

Christina Greisler, APRN

Family · Rocky Hill, CTNPI 1386052710

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.1% of the total across 660 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,183, 3.5 times the $1,212 reported in 2021. Among family clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,815in general payments, 2019–2025

Across 660 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Johnson & Johnson$1K
  • Pfizer$943
  • LEO Pharma Inc.$929
  • UCB, Inc.$902
  • E.r. Squibb & Sons, L.L.C.$829
  • plus $5K from 18 others

What the payments were for

  • Food & beverage$12,44797%
  • Education$3683%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,815 in reported general payments places this provider in the 95th percentile of 1,596 family providers in Connecticut.

See all family providers in Connecticut

Medicare billing

Part B allowed, 2024
$25,015
Medicare patients
109
Services billed
307

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab25$96,975
Clobetasol Propionate57$2,896
Fluorouracil39$2,476
Betamethasone Dipropionate22$580
Triamcinolone Acetonide61$477
Ketoconazole29$360
Clindamycin Phosphate13$298
Hydrocortisone29$124

Paid to pharmacies, not to this prescriber.

Other family in Rocky Hill

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →